IFP Advisors, Inc - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 161 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,123
-86.5%
3,360
-50.0%
0.00%
-100.0%
Q2 2023$52,652
+43.6%
6,720
+100.0%
0.00%
-50.0%
Q1 2023$36,658
+83213.6%
3,360
-14.1%
0.00%
+100.0%
Q4 2022$44
-99.9%
3,913
+1.0%
0.00%0.0%
Q3 2022$43,0000.0%3,876
+0.9%
0.00%0.0%
Q2 2022$43,000
-14.0%
3,842
-14.8%
0.00%0.0%
Q1 2022$50,0004,5070.00%
Q2 2021$0
-100.0%
0
-100.0%
0.00%
Q1 2021$12,0001500.00%
Q4 2020$000.00%
Q3 2020$000.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$00
-100.0%
0.00%
Q3 2019$0
-100.0%
20
-99.9%
0.00%
-100.0%
Q4 2018$302,000
-25.8%
24,958
-0.1%
0.02%
+11.8%
Q3 2018$407,000
-11.3%
24,974
-38.3%
0.02%
-15.0%
Q2 2018$459,000
+678.0%
40,500
+321.9%
0.02%
+566.7%
Q1 2018$59,0000.0%9,6000.0%0.00%0.0%
Q4 2017$59,000
+168.2%
9,600
+71.4%
0.00%
+200.0%
Q3 2017$22,000
+29.4%
5,600
+9.8%
0.00%0.0%
Q2 2017$17,000
-32.0%
5,100
-5.6%
0.00%0.0%
Q1 2017$25,000
-16.7%
5,400
-55.1%
0.00%0.0%
Q4 2016$30,000
+57.9%
12,040
+94.2%
0.00%0.0%
Q3 2016$19,000
+111.1%
6,200
+19.2%
0.00%0.0%
Q2 2016$9,000
-50.0%
5,2000.0%0.00%0.0%
Q4 2015$18,0005,2000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders